Agios Pharmaceuticals, Inc. (AGIO) Stock Total Returns
Growth of $10,000 chart
2021-04-12 to 2026-04-10 to
$
%
%
Loading chart…
Investment Performance
Final Value
$6,302
Total Return
-36.98%
CAGR
-8.83%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +0.16% |
| Median | +0.21% |
| Best | +53.37% |
| Worst | -48.58% |
| % of Windows Positive | 51.1% |
1-Year (252 Trading Days)
| Average | +2.89% |
| Median | -12.16% |
| Best | +183.05% |
| Worst | -71.31% |
| % of Windows Positive | 37.1% |
3-Year (756 Trading Days)
| Average | +14.00% |
| Median | +5.65% |
| Best | +104.38% |
| Worst | -47.26% |
| % of Windows Positive | 61.0% |
Risk Metrics
| Maximum Drawdown | -72.16% |
| Average Drawdown | -44.92% |
| Drawdown Duration | 872 Trading Days |
| Sortino Ratio | 0.21 |
| Calmar Ratio | -0.12 |
| CVaR (5%) | -7.44% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +20.94% (+100.26% ann.) | +$2094.05 | $0.00 | $0.00 | $0.00 |
| 2025 | -17.16% | $1716.37 | $0.00 | $0.00 | $0.00 |
| 2024 | +47.55% | +$4755.27 | $0.00 | $0.00 | $0.00 |
| 2023 | -20.69% | $2069.08 | $0.00 | $0.00 | $0.00 |
| 2022 | -14.57% | $1457.26 | $0.00 | $0.00 | $0.00 |
| 2021 | -24.14% | $2414.03 | $0.00 | $0.00 | $0.00 |
| 2020 | -9.26% | $925.65 | $0.00 | $0.00 | $0.00 |
| 2019 | +3.56% | +$355.67 | $0.00 | $0.00 | $0.00 |
| 2018 | -19.35% | $1934.58 | $0.00 | $0.00 | $0.00 |
| 2017 | +37.00% | +$3699.98 | $0.00 | $0.00 | $0.00 |
| 2016 | -35.72% | $3572.09 | $0.00 | $0.00 | $0.00 |
| 2015 | -42.06% | $4205.64 | $0.00 | $0.00 | $0.00 |
| 2014 | +367.81% | +$36780.79 | $0.00 | $0.00 | $0.00 |
| 2013 partial | -23.43% (-45.64% ann.) | $2343.35 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 24, 2013 – February 19, 2020 | +69.57% | +8.36% | +$6956.52 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -36.59% | -99.45% | $3658.72 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +8.70% | +14.37% | +$870.05 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -12.64% | -12.04% | $1264.45 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -26.08% | -27.45% | $2608.09 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +58.98% | +28.42% | +$5897.71 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 10, 2026 | -27.71% | -18.80% | $2771.19 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.